Skip to content

Healthy Natural US

Menu
  • Newsletter
Menu

Federal Appeals Court Considers If Opioid Distribution Is Public Nuisance

Posted on March 19, 2024


KFF Morning Briefing – The question was posed by a federal appeals court to West Virginia’s highest court on Monday, in a case targeting three major U.S. drug distributors. Separately, the methadone clinic system for treating addiction is in the spotlight.

AP: Appeals Panel Asks West Virginia Court Whether Opioids Distribution Can Cause A Public Nuisance
A federal appeals court asked West Virginia’s highest court Monday whether opioid distributions can cause a public nuisance as it reviews a landmark lawsuit against three major U.S. drug distributors accused of causing a health crisis in one of the state’s counties. In July 2022, a federal judge in Charleston, West Virginia, ruled in favor of AmerisourceBergen Drug Co., Cardinal Health Inc. and McKesson Corp. The lawsuit accused them of distributing 81 million pills over eight years in Cabell County, which has been ravaged by opioid addiction. (Raby, 3/18)
Stat: Leading Voice In Opioid Treatment Defends Methadone Clinic System 
Nobody has made more of an impact on methadone treatment than Mark Parrino. For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor. (Facher, 3/19)
Stat: Private Equity Moves Into The Methadone Clinic Monopoly 
Private equity firms have acquired stakes in nearly one-third of all methadone clinics in recent years, gaining outsize control of the U.S. addiction treatment industry even as the country’s opioid epidemic has developed into a full-fledged public health crisis. (Facher, 3/19)
The Philadelphia Inquirer: Getting Addiction Treatment In Philly Is Difficult And Painful, A Jefferson Study Found
Navigating Philadelphia’s fragmented array of drug treatment programs deters many people with opioid addiction from getting the care they need, a new report from Thomas Jefferson University has found. The city has 60 programs outside of hospitals designed for drug users who are relatively stable, and more than 1,800 beds in residential rehabs. Hospitals and psychiatric hospitals have at least another 150 inpatient beds for those with more intense medical needs. But securing a spot in these programs can be difficult. (Whelan, 3/19)
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.



Source link

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • 14 Canned Goods That Are Going To Cost More In 2025
  • Are These The Worst McDonald’s In America?
  • Supreme Court Lets Trump Enforce Transgender Troop Ban as Cases Proceed
  • Hong Kong Shredded Coconut recalled in Canada because of Salmonella contamination
  • Linda McMahon blasts Harvard in scathing letter telling elite university it will no longer get federal grants

Recent Comments

No comments to show.

Archives

  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023

Categories

  • Health
©2025 Healthy Natural US | Design: Newspaperly WordPress Theme